Dyphylline 100 mg / ephedrine hydrochloride 16 mg / guaifenesin 200 mg / phenobarbital 16 mg Oral Tablet [Lufyllin-EPG]
RxNorm 1116113
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1116113 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dyphylline 100 mg / ephedrine hydrochloride 16 mg / guaifenesin 200 mg / phenobarbital 16 mg Oral Tablet [Lufyllin-EPG].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Dyphylline 100 mg / ephedrine hydrochloride 16 mg / guaifenesin 200 mg / phenobarbital 16 mg Oral Tablet [Lufyllin-EPG]
(Atom ID: 12365220)
TMSY
Tall Man Lettering Synonym (TMSY):
Dyphylline 100 mg / ePHEDrine hydrochloride 16 mg / guaiFENesin 200 mg / PHENobarbital 16 mg Oral Tablet [Lufyllin-EPG]
(Atom ID: 12378688)
SY
Synonym (SY):
Lufyllin-EPG (dyphylline 100 mg / ephedrine hydrochloride 16 mg / guaifenesin 200 mg / phenobarbital 16 mg) Oral Tablet
(Atom ID: 3748497)
TMSY